Plantar Fasciitis Treatment Market Report 2026

Plantar Fasciitis Treatment Market Overview

• Plantar Fasciitis Treatment market size has reached to $2.07 billion in 2025 • Expected to grow to $5.69 billion in 2030 at a compound annual growth rate (CAGR) of 22.2% • Growth Driver: Rising Diabetes Is Anticipated To Fuel Plantar Fasciitis Treatment Market • Market Trend: Adoption of Wearable Long-Duration Ultrasound Devices in Plantar Fasciitis Treatment • North America was the largest region in 2025.

What Is Covered Under Plantar Fasciitis Treatment Market?

Plantar fasciitis treatment refers to the medical care or preventive measures given to a patient to evaluate the incidence and frequency of a degenerative condition of the thick band of tissue at the base of the foot. Physical therapy is an important component of plantar fasciitis treatment. The major types of plantar fasciitis treatment are medication therapy, orthotics, shockwave therapy, surgery, and others. Medication therapy refers to the treatment of any illness or disease through the use of prescription or non-prescription medicines, over-the-counter medications, and herbal medications. It can be diagnosed by medical history, physical examination, X-rays, radiography, and others, and is used by hospitals, clinics, and others.

What Is The Plantar Fasciitis Treatment Market Growth Forecast?

The plantar fasciitis treatment market size is expected to see exponential growth in the next few years. It will grow to $5.69 billion in 2030 at a compound annual growth rate (CAGR) of 22.2%. The growth in the forecast period can be attributed to increasing adoption of advanced diagnostic imaging, rising demand for personalized orthotic products, expansion of outpatient orthopedic treatments, growing focus on preventive musculoskeletal care, increasing integration of physical therapy in treatment protocols. Major trends in the forecast period include increasing adoption of non-invasive treatment options, rising use of shockwave and physical therapy modalities, growing demand for custom orthotic solutions, expansion of multidisciplinary foot care approaches, enhanced focus on early diagnosis and conservative care.

Global Plantar Fasciitis Treatment Market Segmentation

1) By Type: Medication Therapy, Orthotics, Shockwave Therapy, Surgery, Other Types 2) By Diagnosis: Medical History, Physical Examination, X-Rays, Radiography, Other Diagnosis 3) By End User: Hospitals, Clinics, Other End Users Subsegments: 1) By Medication Therapy: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Pain Relievers, Topical Treatments 2) By Orthotics: Custom Orthotic Inserts, Over-The-Counter Insoles, Night Splints, Heel Cups 3) By Shockwave Therapy: Radial Shockwave Therapy, Focused Shockwave Therapy 4) By Surgery: Plantar Fascia Release, Gastrocnemius Recession, Other Surgical Procedures 5) By Other Types: Physical Therapy, Massage Therapy, Stretching And Strengthening Exercises, Alternative Therapies

What Is The Driver Of The Plantar Fasciitis Treatment Market?

The rising diabetes is expected to propel the growth of the plantar fasciitis treatment market. Diabetes is a chronic medical condition characterized by elevated blood sugar levels resulting from insufficient insulin production or ineffective use of insulin by the body. The use of plantar fasciitis treatment in diabetes aims to alleviate foot pain and discomfort associated with inflammation of the plantar fascia, promoting better mobility and reducing the risk of complications. For instance, in 2023, according to a report published by the Health Data Institute, approximately 529 million people worldwide are living with diabetes. Projections suggest that if current trends continue, this figure could escalate to 1.3 billion by 2050. Therefore, the rising diabetes is driving the plantar fasciitis treatment industry.

Key Players In The Global Plantar Fasciitis Treatment Market

Major companies operating in the plantar fasciitis treatment market are Bayer AG, Superfeet Worldwide LLC, Bauerfeind AG, Ottobock SE & Co. KGaA, Sanofi SA, Eli Lilly and Company, GlaxoSmithKline plc, Pfizer Inc., Bristol-Myers Squibb Company, Scholl’s Wellness Co., Hanger Inc., Merck & Co. Inc., Johnson & Johnson Services Inc., Smith & Nephew plc, Arthrex Inc., DJO Global Co., Medline Industries Inc., Bird & Cronin Inc., Aetrex Worldwide Inc., Zimmer Biomet Holdings Inc., Stryker Corporation, Breg Inc., TheraBand LLC, Foot Levelers Inc.

Global Plantar Fasciitis Treatment Market Trends and Insights

Major companies are operating in the plantar fasciitis treatment market, focusing on developing technological advancements such as wearable long-duration ultrasound devices for at-home soft-tissue therapy to enhance healing, reduce pain, and minimize reliance on invasive procedures. A wearable long-duration ultrasound device delivers continuous low-intensity ultrasonic energy directly to soft tissue, stimulating blood flow, oxygenation, and cellular repair providing a non-invasive alternative to traditional orthotics, pain medications, or corticosteroid injections. For instance, in June 2025, ZetrOZ Systems, a US-based medical device manufacturer, launched the sam 2.0, an advanced wearable ultrasound device for plantar fasciitis treatment. The product delivers multi-hour, low-intensity ultrasound therapy that promotes collagen deposition, accelerates soft-tissue repair, reduces inflammation, and can be self-administered at home, offering patients a convenient, drug-free, non-surgical treatment option.

What Are Latest Mergers And Acquisitions In The Plantar Fasciitis Treatment Market?

In September 2024, Bansk Group, a US-based investment firm, acquired Foundation Wellness for an undisclosed amount. Through this acquisition, Bansk Group aims to strengthen its plantar fasciitis treatment portfolio by integrating Foundation Wellness’s specialty orthotics, insoles, and foot-care solutions, expanding its offerings for foot pain relief. Foundation Wellness is a US-based company that provides orthotics, footbeds or insoles, orthopedic braces, and wellness-focused foot-care products specifically designed to address plantar fasciitis and other foot-related conditions.

Regional Outlook

North America was the largest region in the plantar fasciitis treatment market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Plantar Fasciitis Treatment Market?

The plantar fasciitis treatment market includes revenues earned by entities by provide extracorporeal shock wave therapy (ESWT), intracorporeal pneumatic shock wave therapy (IPST), inflammation-related pain drugs, and non-operative treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Plantar Fasciitis Treatment Market Report 2026?

The plantar fasciitis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the plantar fasciitis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.